Back In 2018, the National Dialogue for Healthcare Innovation convened in Washington DC to address the nation’s opioid crisis, uniting leaders from various sectors to develop actionable solutions. The Opioid Solutions Summit, a critical component of this dialogue, explored areas such as opioid care management, technology and data analytics, and therapeutic innovation. Derek Daley, Co-Founder of Legacy Treatment Center, played an active role in crafting recommended actions for Congress, regulatory entities, and private-sector healthcare leaders.
At the forefront of the National Opioid Summit, Derek Daley collaborated with leaders to push for systemic changes in response to the devastating consequences of opioid misuse and addiction. Their advocacy focused on two pivotal proposals: e-prescribing for controlled substances and the establishment of a national prescription drug monitoring program (PDMP).
The introduction of e-prescribing for controlled substances has been recognized as a transformative advancement in prescription practices. By digitizing prescriptions, the risk of fraudulent prescriptions and medication diversion can be significantly mitigated. Real-time monitoring and tracking capabilities provide healthcare professionals with the necessary tools to promptly identify potential patterns of misuse or abuse. This groundbreaking measure aims to curb the opioid epidemic and enhance patient safety.
In parallel, Derek joined representatives to advocate for the establishment of a national PDMP, which would centralize the tracking and monitoring of prescription drug dispensing across the nation. Equipped with real-time information, healthcare providers are empowered to make informed decisions when prescribing controlled substances. Timely intervention and appropriate treatment referrals can be facilitated, leading to early identification of patients at risk of addiction or overdose. Legacy Treatment Center’s commitment to the PDMP exemplifies their dedication to a proactive and coordinated approach in addressing the opioid crisis.
Beyond the National Opioid Summit, Derek continues his impactful advocacy work. Through collaboration with professionals and policymakers, he played an instrumental role in developing a congressional bill aligned with the proposed changes discussed at the summit. Legacy Treatment Center’s ongoing efforts have made a lasting impact on individuals affected by opioid addiction.
Legacy Treatment Center’s participation in the 2018 National Opioid Summit demonstrates their unwavering commitment to combat the devastating effects of the epidemic. By embracing collaborative solutions and advocating for systemic changes such as e-prescribing and the PDMP, Legacy Treatment Center remains at the forefront of addressing the opioid crisis. Through close collaboration with policymakers and professionals, they strive to enhance safety, accountability, and the overall effectiveness of opioid prescribing practices. Legacy Treatment Center’s ongoing commitment offers hope to those affected by addiction and reinforces their determination to create a brighter future amidst the ongoing battle against the opioid epidemic.
Today, Derek Daley continues his advocacy work as the Vice President of NATSAP (National Association of Therapeutic Schools and Programs). In this capacity, he collaborates with policymakers to craft policies that better protect and care for individuals suffering from mental health and addiction. Building upon his experience and successes at the National Opioid Summit, Derek’s unwavering dedication and expertise contribute to shaping meaningful changes in the field of mental health and addiction treatment. Through his ongoing advocacy efforts, Derek remains steadfast in his commitment to making a lasting impact and improving the lives of those affected by these pressing issues.
You can read more about the National Dialogue for Healthcare Innovation and the road map for action here.